Today, the Commission is proposing to revise the EU's pharmaceutical legislation - the largest reform in over 20 years - to make it more agile, flexible, and adapted to the needs of citizens and businesses across the EU. The revision will make medicines more available, accessible and affordable. It will support innovation and boost the competitiveness and attractiveness of the EU pharmaceutical industry, while promoting higher environmental standards. In addition to this reform, the Commission proposes a Council Recommendation to step up the fight against antimicrobial resistance (AMR).
Commission proposes pharmaceuticals reform for more accessible, affordable and innovative medicines
31.08.2023 - 21:00

BGNES

Watch and Comment news
7,000 Steps a Day Can Improve Your Health
14.08.2025 - 01:01
Bayer signs $1.3 billion deal to develop cancer drug
13.08.2025 - 11:39
“No screens in the bedroom”: a simple rule that would make a difference?
13.08.2025 - 08:29
Monica Seles suffers from rare disease affecting vision and muscles
13.08.2025 - 01:00
France bans pesticide acetamiprid
12.08.2025 - 13:27
‘Natural’ doesn’t always mean safe: dermatologist debunks cosmetics myth
12.08.2025 - 11:35